TP53 and neoplasm: Additionally, the same group reported that sclareol enhances the activity of known anticancer drugs such as doxorubicin, etoposide, and cisplatin against human breast cancer cells [87], in addition to inducing apoptosis in human tumor cell lines and suppressing tumor growth in vivo via a p53-independent mechanism of action [88].